Heidi W. Moore

All articles by Heidi W. Moore

ACR Convergence 2020

Anifrolumab May Reduce Skin Disease Severity in Patients With Active Systemic Lupus Erythematosus

Heidi W. Moore

November 7, 2020

Researchers evaluated the effect on skin-specific systemic lupus erythematosus disease activity using data pooled from the TULIP-1 and TULIP-2 trials.

Psoriasis and psoriatic arthritis increase cardiovascular risks.

EULAR 2020 Coverage

Do TNFis Reduce the Risk for Progression to PsA in Patients With Psoriasis?

Heidi W. Moore

June 5, 2020

Researchers evaluated the use of TNFis vs methotrexate in reducing the risk for progression to psoriatic arthritis in patients with psoriasis.

In-Depth Focus from ACR 2019: SpA

Secukinumab Improves Nail Psoriasis, Inhibition of Radiographic Progression in Psoriatic Arthritis

Heidi W. Moore

November 18, 2019

Researchers reported on the efficacy of secukinumab in patients with psoriatic arthritis and nail psoriasis and other elements of the disease, including radiographic progression.

Next post in In-Depth Focus from ACR 2019: SpA

Heidi W. Moore

All articles by Heidi W. Moore

Anifrolumab May Reduce Skin Disease Severity in Patients With Active Systemic Lupus Erythematosus

Do TNFis Reduce the Risk for Progression to PsA in Patients With Psoriasis?

Secukinumab Improves Nail Psoriasis, Inhibition of Radiographic Progression in Psoriatic Arthritis

Higher Rates of Treated Depression With Corticosteroids, Interleukin Inhibitors in PsA